According to reports, Pfizer is trying to get an authorization for a second booster shot for senior citizens, per sources that are reportedly familiar with the impending plans.
Pfizer and BioNTech are reportedly expected to request authorization from the Food and Drug Administration sometime in the coming week to approve another round of COVID booster shots for people ages 65 and older.
Currently, the FDA has already approved the first round of booster shots under an emergency basis for anyone aged 12 or older.
The news of Pfizer allegedly planning to persuade the FDA into granting more boosters for the elderly population comes amidst a period where a myriad of reports have been coming out that have caused various levels of concern regarding Pfizer’s brand of COVID shots.
For instance, this week, Red Voice Media shared a report on how Dr. Naomi Wolf has been pouring over some of the more recent Pfizer documents that have been released which detail concerning findings when the jab was being tested on lab rats.
Dr. Wolf even admitted that she’s teamed up with over 160 attorneys in these efforts, as “the crimes are of such an extraordinary scale as we’re starting to see what was really done to the American people and to people around the world.”
Furthermore, another report Red Voice Media released earlier in March showcased the unsettling trends around cases of pericarditis and myocarditis as listed adverse reactions to the COVID jabs within the first two months of 2022.
With respect to those trends, there were a total of 24,177 instances of pericarditis or myocarditis transpiring in the wake of the COVID shots in all of 2021. However, between the onset of 2022 up until February 25th, there were 11,289 reported cases of pericarditis or myocarditis following the jab – meaning that in the first two months in 2022, VAERS has recorded 47% of the reported cases equivalent to all of 2021.
And, as it would turn out, the Pfizer shots happen to hold the lion’s share of these very sort of adverse reactions, according to Open VAERS data. And now this same company is looking for round two of boosters for seniors.
Red Voice Media would like to make a point of clarification on why we do not refer to any shot related to COVID-19 as a "vaccine." According to the CDC, the definition of a vaccine necessitates that said vaccine have a lasting effect of at least one year in preventing the contraction of the virus or disease it's intended to fight. Because all of the COVID-19 shots thus far available have barely offered six months of protection, and even then not absolute, Red Voice Media has made the decision hereafter to no longer refer to the Pfizer, Moderna, or Johnson & Johnson substances as vaccinations.